Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eduardo Caleiras

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Pathology, Research and Practice|July 9, 2004
Extranodal Rosai-Dorfman disease. Clinical and pathological characteristics in a patient with a pseudotumor of boneJosé David Mota Gamboa, Eduardo Caleiras, Arturo Rosas-Uribe
Revista Do Instituto De Medicina Tropical De Sao Paulo|July 13, 2007
Human infection by Angiostrongylus costaricensis in Venezuela: first report of a confirmed caseRenzo Nino Incani, Eduardo Caleiras, Milena Martín, et al.
Investigacion Clinica|August 25, 2015
[Cadherins E and P expression in the molecular types of breast cancer]Ángel Fernández, Aldo Reigosa, Eduardo Caleiras, et al.
Investigacion Clinica|April 22, 2017
Subclassification of the molecular types of breast cancer based on the expression of immunohistochemical markers and evolutionAldo Reigosa, David Hardisson, Francisco Sanzi, et al.
Frontiers in Immunology|December 7, 2018
Ly9 (CD229) Antibody Targeting Depletes Marginal Zone and Germinal Center B Cells in Lymphoid Tissues and Reduces Salivary Gland Inflammation in a Mouse Model of Sjögren's SyndromeJoan Puñet-Ortiz, Manuel Sáez Moya, Marta Cuenca, et al.
Investigacion Clinica|June 6, 2008
[HER2/neu expression in Venezuelan patients with locally advanced breast cancer]Luisa Morales, Aldo Reigosa, Eduardo Caleiras, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 18, 2023
Distribution of PD-L1, TROP2 and HER2- "lowness" in early triple-negative breast cancer: an opportunity for treatment de-escalationMaria Jose Bueno, Silvana Mouron, Eduardo Caleiras, et al.
Cancers|July 2, 2021
[6]-Gingerol-Derived Semi-Synthetic Compound SSi6 Inhibits Tumor Growth and Metastatic Dissemination in Triple-Negative Breast Cancer Xenograft ModelsLiany Luna-Dulcey, James Almada da Silva, Veronica Jimenez-Renard, et al.
Breast Cancer Research : BCR|February 13, 2021
FGFR1 amplification or overexpression and hormonal resistance in luminal breast cancer: rationale for a triple blockade of ER, CDK4/6, and FGFR1Silvana Mouron, Luis Manso, Eduardo Caleiras, et al.
Cell Reports|July 14, 2021
Inhibition of Rag GTPase signaling in mice suppresses B cell responses and lymphomagenesis with minimal detrimental trade-offsAna Ortega-Molina, Cristina Lebrero-Fernández, Alba Sanz, et al.
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Pathology, Research and Practice|July 9, 2004
Extranodal Rosai-Dorfman disease. Clinical and pathological characteristics in a patient with a pseudotumor of boneJosé David Mota Gamboa, Eduardo Caleiras, Arturo Rosas-Uribe
Revista Do Instituto De Medicina Tropical De Sao Paulo|July 13, 2007
Human infection by Angiostrongylus costaricensis in Venezuela: first report of a confirmed caseRenzo Nino Incani, Eduardo Caleiras, Milena Martín, et al.
Investigacion Clinica|August 25, 2015
[Cadherins E and P expression in the molecular types of breast cancer]Ángel Fernández, Aldo Reigosa, Eduardo Caleiras, et al.
Investigacion Clinica|April 22, 2017
Subclassification of the molecular types of breast cancer based on the expression of immunohistochemical markers and evolutionAldo Reigosa, David Hardisson, Francisco Sanzi, et al.
Frontiers in Immunology|December 7, 2018
Ly9 (CD229) Antibody Targeting Depletes Marginal Zone and Germinal Center B Cells in Lymphoid Tissues and Reduces Salivary Gland Inflammation in a Mouse Model of Sjögren's SyndromeJoan Puñet-Ortiz, Manuel Sáez Moya, Marta Cuenca, et al.
Investigacion Clinica|June 6, 2008
[HER2/neu expression in Venezuelan patients with locally advanced breast cancer]Luisa Morales, Aldo Reigosa, Eduardo Caleiras, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 18, 2023
Distribution of PD-L1, TROP2 and HER2- "lowness" in early triple-negative breast cancer: an opportunity for treatment de-escalationMaria Jose Bueno, Silvana Mouron, Eduardo Caleiras, et al.
Cancers|July 2, 2021
[6]-Gingerol-Derived Semi-Synthetic Compound SSi6 Inhibits Tumor Growth and Metastatic Dissemination in Triple-Negative Breast Cancer Xenograft ModelsLiany Luna-Dulcey, James Almada da Silva, Veronica Jimenez-Renard, et al.
Breast Cancer Research : BCR|February 13, 2021
FGFR1 amplification or overexpression and hormonal resistance in luminal breast cancer: rationale for a triple blockade of ER, CDK4/6, and FGFR1Silvana Mouron, Luis Manso, Eduardo Caleiras, et al.
Cell Reports|July 14, 2021
Inhibition of Rag GTPase signaling in mice suppresses B cell responses and lymphomagenesis with minimal detrimental trade-offsAna Ortega-Molina, Cristina Lebrero-Fernández, Alba Sanz, et al.
Pageof 6